OPG awards contract for complex parts for nuclear refurbishment

Peterborough – Ontario Power Generation (OPG) and BWX Technologies, Inc. (NYSE: BWXT) are announcing a contract for Fuelling Machine (FM) head engineering and component supply as part of refurbishment of the Darlington Nuclear Generating Station. The contract will be formally announced today at BWXT’s Peterborough, Ontario, facility, with Energy Minister Todd Smith, Peterborough-Kawartha MPP Dave Smith, […]

BWXT to Restart Existing TRISO Nuclear Fuel Production Line and Expand Capacity

Company to hireup to 60 new workers to attain increased production targets (LYNCHBURG, Va. – Oct. 2, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it is in the process of restarting its existing TRISO nuclear fuel production line and is planning to expand its existing capacity within approximately 12 months. The expansion […]

BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225

(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies […]

BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power

(CAMBRIDGE, ON – August 19, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers.  The contract, which will be executed by subsidiary BWXT Canada Ltd. at its Cambridge, Ontario facility, involves engineering and fabrication of these specialized components. Moderator […]

BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific

(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company.  Developed for the treatment of patients with hepatocellular carcinoma (HCC), TheraSphere treatment is comprised of millions […]

BWXT Expands Technical Fellows Program

Diverse Team of Employees Selectedfor Scientific and Engineering Contributions (LYNCHBURG, Va. – April 27, 2021) – BWX Technologies, Inc. (NYSE: BWXT) has expanded its existing technical fellows initiative by selecting 25 additional employees for the program in recognition of their scientific and engineering accomplishments at the company. Individuals selected as fellows are recognized as senior […]

BWXT Announces $2.2 Billion in Contracts for Naval Nuclear Reactor Components and Fuel

(LYNCHBURG, Va. – April 20, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today the award of U.S. Naval Nuclear Propulsion Program contracts totaling approximately $2.2 billion, including future-year options, for the manufacture of naval nuclear reactor components and fuel. “Today’s announcement marks a continuation of a more-than 65-year-old trusted relationship with the U.S. government […]

This Website Uses Cookies.

We use cookies to give you the best user experience. No personal information is collected in this process.